Drug epidemiology and post-marketing surveillance
Author(s)
Bibliographic Information
Drug epidemiology and post-marketing surveillance
(NATO ASI series, Ser. A . Life science ; v. 224)
Plenum Press, c1992
Available at 7 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
"Proceedings of a NATO Advanced Study Institute on Drug Epidemiology and Post-Marketing Surveillance, held September 27-October 8, 1990, in Erice, Sicily, Italy"--T.p. verso
"Published in cooperation with NATO Scientific Affairs Division."
Includes bibliographical references and index
Description and Table of Contents
Description
This volume is a summary of material presented in the course given in the International School of Phannacology on "Drug Epidemiology and Post-Marketing Surveillance" between September 27 and October 8, 1990, at the "Ettore Majorana Center for Scientific Culture" in Erice, Sicily. The course, which was a NATO Advanced Study Institute, included lectures and workshops presented by experts in the new field of phannacoepidemiology. The material covered includes various approaches to spontaneous reporting of adverse drug reactions, including aggregate approaches, such as those used in France, and detailed analyses of individual reports, such as that done in The Netherlands and in Sweden. Also, included are studies using traditional epidemiology methods. In addition, modern pharmacoepidemiology makes considerable use of automated databases. As such, information is presented on their use as well. Phannacoepidemiology started in hospitals and some of the newest work in the field is returning to the hospital as a site for studies. Material on these topics was presented as well. Finally, selected new methodologic developments were outlined in specific examples presented that were of regulatory and commercial importance. This new field of phannacoepidemiology is exploding in interest internationally. Evidence of this is the increasing development of pharmacoepidemiology programs in industry, medical schools, pharmacy schools, and schools of public health. Also, there is a new International Society ofPhannacoepidemiology. Practitioners in this field tend to specialize in either analyses of spontaneous reporting or the use of formal epidemiologic techniques.
Table of Contents
- Spontaneous Reporting: The Analysis of Postmarketing Drug Surveillance Data at the U.S. Food and Drug Administration
- T.P. Gross. Pharmacovigilance in France
- B. Begaud. Traditional Clinical Epidemiology Methods as Applied to Pharmacoepidemiology: The Use of Cohort Studies in Pharmacoepidemiology
- T. Creagh-Kirk. Use of Automated Databases for Pharmacoepidemiology: Screening for Unknown Effects of Newly Marketed Drugs
- J.L. Carson, B.L. Strom. Hospital Pharmacoepidemiology: Hospital Data Sources
- J.K. Jones. New Methodologic Developments: Approaches to Evaluating Causation of Suspected Drug Reactions
- J.K. Jones. Pharmacoeconomics
- H. Glick, R. Kington. Selected Examples of Regulatory and Commercial Importance: The Triazolam Experience in 1979 in the Netherlands
- R.H.B. Meyboom. Eleven additional articles. Index.
by "Nielsen BookData"